Retail sale of other food
LAB PHARMA AS
Revenue 2024
NOK 26.2m
Operating profit
NOK −2.9m
Equity
NOK −2.2m
Incorporated
2011
Share capital
NOK 500,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 26.2m | |
| Total operating costs | 29.2m | |
| Operating profit (EBIT) | −2.9m | |
| Net financial items | 302k | |
| Profit for the year | −3.9m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 5.6m | |
| of which current assets | 5.1m | |
| Equity | −2.2m | |
| Total liabilities | 7.8m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.